Entera Cost of Revenue vs Deferred Revenue Analysis

ENTX Stock  USD 1.54  0.01  0.65%   
Trend analysis of Entera Bio balance sheet accounts such as Other Current Liabilities of 1.3 M or Total Current Liabilities of 1 M provides information on Entera Bio's total assets, liabilities, and equity, which is the actual value of Entera Bio to its prevalent stockholders. By breaking down trends over time using Entera Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

About Entera Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Entera Bio at a specified time, usually calculated after every quarter, six months, or one year. Entera Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Entera Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Entera currently owns. An asset can also be divided into two categories, current and non-current.

Entera Bio Balance Sheet Chart

Entera Bio Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Entera Bio uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Entera Bio's Non Current Liabilities Other is fairly stable compared to the past year. Net Working Capital is likely to rise to about 12.9 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 370.5 K in 2024.

Total Assets

Total assets refers to the total amount of Entera Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Entera Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Entera Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Entera Bio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Entera Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Entera Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.Selling General Administrative is likely to rise to about 5.2 M in 2024, despite the fact that Tax Provision is likely to grow to (16.1 K).
 2023 2024 (projected)
Interest Income854.5K696.3K
Reconciled Depreciation59K84.1K

Entera Bio fundamental ratios Correlations

-0.750.680.20.820.820.810.61-0.96-0.720.050.99-0.24-0.821.00.54-0.670.280.77-0.640.590.721.0-0.6-0.520.61
-0.75-0.380.31-0.86-0.45-0.86-0.510.90.82-0.35-0.730.250.65-0.77-0.560.75-0.17-0.830.8-0.68-0.91-0.750.630.66-0.63
0.68-0.380.240.430.60.420.75-0.6-0.23-0.410.680.16-0.40.670.02-0.3-0.090.29-0.270.390.360.68-0.26-0.240.44
0.20.310.240.050.350.030.110.010.06-0.090.190.24-0.440.18-0.09-0.14-0.18-0.010.030.14-0.220.2-0.240.080.23
0.82-0.860.430.050.541.00.6-0.88-0.880.20.8-0.31-0.740.830.66-0.960.250.93-0.960.740.720.82-0.92-0.720.69
0.82-0.450.60.350.540.520.41-0.71-0.320.120.80.18-0.580.810.25-0.40.00.46-0.340.50.510.81-0.36-0.120.63
0.81-0.860.420.031.00.520.62-0.88-0.90.180.79-0.34-0.740.820.68-0.960.270.94-0.970.750.720.82-0.92-0.750.67
0.61-0.510.750.110.60.410.62-0.62-0.56-0.410.64-0.09-0.470.620.42-0.540.130.6-0.530.70.520.61-0.5-0.620.48
-0.960.9-0.60.01-0.88-0.71-0.88-0.620.83-0.19-0.960.290.78-0.96-0.640.73-0.31-0.860.74-0.69-0.85-0.960.640.63-0.66
-0.720.82-0.230.06-0.88-0.32-0.9-0.560.83-0.21-0.740.560.75-0.74-0.860.83-0.5-0.940.85-0.72-0.71-0.730.770.9-0.55
0.05-0.35-0.41-0.090.20.120.18-0.41-0.19-0.210.060.12-0.210.050.21-0.22-0.090.25-0.240.270.380.05-0.170.040.43
0.99-0.730.680.190.80.80.790.64-0.96-0.740.06-0.29-0.780.990.63-0.640.380.79-0.610.620.710.99-0.57-0.560.62
-0.240.250.160.24-0.310.18-0.34-0.090.290.560.12-0.290.21-0.27-0.730.27-0.92-0.510.310.11-0.2-0.270.250.430.33
-0.820.65-0.4-0.44-0.74-0.58-0.74-0.470.780.75-0.21-0.780.21-0.81-0.490.68-0.14-0.720.61-0.62-0.66-0.820.650.58-0.56
1.0-0.770.670.180.830.810.820.62-0.96-0.740.050.99-0.27-0.810.57-0.670.320.79-0.650.590.741.0-0.61-0.540.6
0.54-0.560.02-0.090.660.250.680.42-0.64-0.860.210.63-0.73-0.490.57-0.610.810.86-0.630.540.540.56-0.57-0.690.33
-0.670.75-0.3-0.14-0.96-0.4-0.96-0.540.730.83-0.22-0.640.270.68-0.67-0.61-0.18-0.890.99-0.74-0.58-0.670.990.71-0.67
0.28-0.17-0.09-0.180.250.00.270.13-0.31-0.5-0.090.38-0.92-0.140.320.81-0.180.49-0.21-0.030.170.31-0.16-0.37-0.21
0.77-0.830.29-0.010.930.460.940.6-0.86-0.940.250.79-0.51-0.720.790.86-0.890.49-0.90.740.780.78-0.83-0.740.58
-0.640.8-0.270.03-0.96-0.34-0.97-0.530.740.85-0.24-0.610.310.61-0.65-0.630.99-0.21-0.9-0.72-0.63-0.640.950.73-0.64
0.59-0.680.390.140.740.50.750.7-0.69-0.720.270.620.11-0.620.590.54-0.74-0.030.74-0.720.650.58-0.69-0.70.89
0.72-0.910.36-0.220.720.510.720.52-0.85-0.710.380.71-0.2-0.660.740.54-0.580.170.78-0.630.650.72-0.47-0.450.53
1.0-0.750.680.20.820.810.820.61-0.96-0.730.050.99-0.27-0.821.00.56-0.670.310.78-0.640.580.72-0.61-0.530.59
-0.60.63-0.26-0.24-0.92-0.36-0.92-0.50.640.77-0.17-0.570.250.65-0.61-0.570.99-0.16-0.830.95-0.69-0.47-0.610.67-0.63
-0.520.66-0.240.08-0.72-0.12-0.75-0.620.630.90.04-0.560.430.58-0.54-0.690.71-0.37-0.740.73-0.7-0.45-0.530.67-0.51
0.61-0.630.440.230.690.630.670.48-0.66-0.550.430.620.33-0.560.60.33-0.67-0.210.58-0.640.890.530.59-0.63-0.51
Click cells to compare fundamentals

Entera Bio Account Relationship Matchups

Entera Bio fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets16.7M10.3M26.0M13.1M11.8M13.9M
Other Current Liab3.8M(189K)2.8M(134K)874K1.3M
Total Current Liabilities4.6M3.3M3.2M1.3M1.1M1.0M
Total Stockholder Equity11.9M6.7M22.6M11.8M10.4M10.9M
Net Tangible Assets11.3M6.1M22.6M11.8M13.5M14.2M
Property Plant And Equipment Net462K192K395K139K488K305.4K
Net Debt(14.9M)(8.2M)(24.6M)(12.2M)(10.6M)(11.2M)
Retained Earnings(62.9M)(72.9M)(82.4M)(95.5M)(104.4M)(99.2M)
Accounts Payable334K1.8M166K1.3M83K78.9K
Cash15.2M8.6M24.9M12.3M11.0M11.8M
Non Current Assets Total1.1M1.2M658K278K508K631.1K
Cash And Short Term Investments15.2M8.6M24.9M12.3M11.0M12.3M
Common Stock Shares Outstanding12.1M18.4M26.1M28.8M29.0M19.3M
Liabilities And Stockholders Equity16.7M10.3M26.0M13.1M11.8M13.9M
Non Current Liabilities Total192K324K261K32K288K273.6K
Other Current Assets97K93K254K294K238K188.5K
Other Stockholder Equity63.4M70.6M105.0M107.2M114.7M63.3M
Total Liab4.8M3.6M3.4M1.4M1.4M1.3M
Property Plant And Equipment Gross462K548K395K229K488K359.9K
Total Current Assets15.6M9.1M25.3M12.8M11.3M13.0M
Accumulated Other Comprehensive Income13.1M11.4M9.0M41K36.9K35.1K
Property Plant Equipment462K548K395K229K263.4K337.8K
Non Currrent Assets Other(1.1M)356K46K96K6K5.7K
Net Invested Capital11.9M6.7M22.6M11.8M10.4M7.2M
Net Working Capital11.0M5.8M22.2M11.5M10.2M12.9M
Current Deferred Revenue267K1.4M15K43K38.7K36.8K
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Entera Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Entera Bio's short interest history, or implied volatility extrapolated from Entera Bio options trading.

Pair Trading with Entera Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Entera Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Entera Stock

  0.69MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.77EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against Entera Stock

  0.93KA Kineta Inc Report 29th of March 2024 PairCorr
  0.85TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.82MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.79MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.76DBVT DBV Technologies Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Entera Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Entera Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Entera Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Entera Bio to buy it.
The correlation of Entera Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entera Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entera Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Entera Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Entera Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Entera Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Entera Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Entera Bio Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Entera Stock analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stocks Directory
Find actively traded stocks across global markets
Is Entera Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entera Bio. If investors know Entera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entera Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.31)
Quarterly Revenue Growth
(0.92)
Return On Assets
(0.45)
Return On Equity
(0.80)
The market value of Entera Bio is measured differently than its book value, which is the value of Entera that is recorded on the company's balance sheet. Investors also form their own opinion of Entera Bio's value that differs from its market value or its book value, called intrinsic value, which is Entera Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entera Bio's market value can be influenced by many factors that don't directly affect Entera Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entera Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Entera Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entera Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.